Company intelligence / Profile preview
Roche
Basel, Basel-Stadt, Switzerlandroche.com ↗
- Ownership
- Public · RHHBY
- Employees
- ~100000
- Development stage
- Other
01
Overview
Roche is a global leader in pharmaceuticals and diagnostics with numerous commercial products and a diverse pipeline. Recent research setbacks have led to cutting about 20% of its pipeline in recent quarters as the company refocuses on innovation.
- Therapeutic areas
- CardiovascularOphthalmologyImmunologyEndocrinologyOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesbiologicsgene therapycell therapyantibodies
- Industry
- Pharma
02
Drug pipeline
453 assets452 more assets in the full pipeline.
03
Financials
- Market cap
- $378.9B
- Total revenue
- $77.4B
- Enterprise value
- $405.8B
Beyond the preview
Go deeper on Roche.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Roche.